SUNHERE(SZ:300452)2021-08-27 16:00Financial Performance - The company's operating revenue for the first half of 2021 was CNY 305,526,752.22, representing an increase of 18.55% compared to CNY 257,715,068.45 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was CNY 53,265,124.19, up by 6.41% from CNY 50,057,446.13 in the previous year[21]. - The net cash flow from operating activities increased significantly by 76.15%, reaching CNY 44,783,605.11 compared to CNY 25,423,456.80 in the same period last year[21]. - The basic earnings per share rose to CNY 0.30, reflecting a growth of 7.14% from CNY 0.28 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was CNY 48,206,486.75, which is a 7.22% increase from CNY 44,960,895.08 in the same period last year[21]. - The company achieved total operating revenue of 305.53 million yuan, an increase of 18.55% year-on-year, with a net profit attributable to shareholders of 53.27 million yuan, up 6.41%[35]. - The company reported a significant increase in user data, with a total of 1.78 million users engaged with its products[168]. - The total comprehensive income for the first half of 2021 was approximately 48.22 million yuan, reflecting a significant increase compared to the previous period[177]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 900,578,474.75, a slight decrease of 0.03% from CNY 900,871,586.44 at the end of the previous year[21]. - The total amount of entrusted financial management was ¥19,000,000, with no overdue amounts reported[58]. - The company's total liabilities decreased to CNY 236,306,665.46 from CNY 245,696,995.30, representing a decline of 3.06%[142]. - The company's total liabilities at the end of the reporting period were approximately 793.56 million yuan, indicating a manageable debt level[178]. Research and Development - The company's R&D investment increased by 29.44% to ¥11,205,938.48 from ¥8,657,180.75 in the previous year[45]. - The company holds 16 national invention patents related to pharmaceutical excipients, enhancing its R&D capabilities[40]. - The company is focusing on enhancing its research and development capabilities to drive innovation in its product offerings[166]. Market Position and Products - The company specializes in the research, production, and sales of pharmaceutical excipients, ranking among the top suppliers in China for oral solid dosage forms[28]. - Key products include microcrystalline cellulose, hydroxypropyl cellulose, and sodium carboxymethyl starch, which have been recognized as high-tech products in Anhui Province[28]. - The company has diversified its product range from 5 to 30 varieties, enhancing its competitiveness in the pharmaceutical excipient industry[38]. - The company is a leading domestic producer of pharmaceutical excipients, with a supply scale ranking among the top in the industry, offering 30 varieties and over 70 specifications[42]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[83]. - The COD discharge after treatment was 182 mg/l, below the standard of 500 mg/l, with a total discharge of 50,183 kg[83]. - The company has implemented a stock incentive plan approved by the shareholders meeting on November 20, 2020[79]. - The company has a wastewater treatment system with a designed capacity of 1,000 tons per day, which is currently operating normally and meets discharge standards[86]. Strategic Plans - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company plans to continue expanding its market presence and investing in new product development in the upcoming quarters[177]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product portfolio[166]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,876[125]. - The total number of shares before the change was 180,467,070, with no new shares issued or other changes[120]. - The company reported a significant shareholder equity change, with a holding ratio dropping below 5% on June 25, 2021[116]. Financial Reporting - The semi-annual financial report for the company has not been audited[97]. - The financial statements are prepared based on the going concern assumption and comply with the latest accounting standards issued by the Ministry of Finance[187]. - The consolidated financial statements are prepared based on the accounting policies and periods consistent with the company[200].